ABN AMRO Investment Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.5M Buy
147,546
+35,415
+32% +$2.03M 0.07% 175
2026
Q1
$6.8M Buy
112,131
+13,812
+14% +$805K 0.09% 165
2025
Q4
$5.3M Buy
98,319
+74,202
+308% +$3.57M 0.08% 190
2025
Q3
$1.09M Sell
24,117
-704
-3% -$32.9K 0.02% 286
2025
Q2
$1.15M Hold
24,821
0.02% 289
2025
Q1
$1.51M Sell
24,821
-517
-2% -$30.1K 0.03% 272
2024
Q4
$1.43M Sell
25,338
-6,603
-21% -$369K 0.03% 281
2024
Q3
$1.65M Buy
31,941
+3,058
+11% +$143K 0.03% 272
2024
Q2
$1.2M Buy
28,883
+14,379
+99% +$643K 0.02% 295
2024
Q1
$787K Sell
14,504
-276
-2% -$14.1K 0.01% 315
2023
Q4
$758K Buy
14,780
+797
+6% +$41.8K 0.01% 313
2023
Q3
$812K Sell
13,983
-7,834
-36% -$480K 0.02% 303
2023
Q2
$1.4M Sell
21,817
-35,802
-62% -$2.4M 0.03% 265
2023
Q1
$3.99M Buy
+57,619
New +$4.06M 0.08% 185

Other funds holding BMY

ABN AMRO Investment Solutions's BMY Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Bristol-Myers Squibb (BMY) stake by 32% in Q2 2026, buying an estimated $2.03M and bringing the position to 147,546 shares worth $8.5M. The position accounts for 0.07% of the portfolio, ranked #175.

ABN AMRO Investment Solutions first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. 830 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • ABN AMRO Investment Solutions held 147,546 shares of Bristol-Myers Squibb worth $8.5M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 35,415 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.03M.
  • Bristol-Myers Squibb made up 0.07% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #175 holding.
  • ABN AMRO Investment Solutions first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
  • 830 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.